Compare ABCL & GDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABCL | GDRX |
|---|---|---|
| Founded | 2012 | 2011 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 868.9M |
| IPO Year | 2020 | 2020 |
| Metric | ABCL | GDRX |
|---|---|---|
| Price | $3.98 | $2.30 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 10 |
| Target Price | ★ $7.75 | $4.78 |
| AVG Volume (30 Days) | ★ 5.0M | 2.3M |
| Earning Date | 02-24-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.09 |
| Revenue | $35,325,000.00 | ★ $800,651,000.00 |
| Revenue This Year | $25.45 | $2.30 |
| Revenue Next Year | $10.07 | $2.63 |
| P/E Ratio | ★ N/A | $26.94 |
| Revenue Growth | ★ 7.17 | 1.30 |
| 52 Week Low | $1.89 | $2.27 |
| 52 Week High | $6.52 | $5.81 |
| Indicator | ABCL | GDRX |
|---|---|---|
| Relative Strength Index (RSI) | 47.97 | 22.62 |
| Support Level | $3.92 | $2.27 |
| Resistance Level | $4.25 | $2.63 |
| Average True Range (ATR) | 0.31 | 0.12 |
| MACD | -0.02 | -0.04 |
| Stochastic Oscillator | 6.94 | 5.07 |
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.